Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0003 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |